Paragon Care Ltd
ASX:PGC
Intrinsic Value
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. [ Read More ]
The intrinsic value of one PGC stock under the Base Case scenario is 0.45 AUD. Compared to the current market price of 0.34 AUD, Paragon Care Ltd is Undervalued by 25%.
Valuation Backtest
Paragon Care Ltd
Run backtest to discover the historical profit from buying and selling PGC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Paragon Care Ltd
Current Assets | 139.2m |
Cash & Short-Term Investments | 28.4m |
Receivables | 39.6m |
Other Current Assets | 71.2m |
Non-Current Assets | 339.2m |
Long-Term Investments | 2.1m |
PP&E | 64.9m |
Intangibles | 260.1m |
Other Non-Current Assets | 12.1m |
Current Liabilities | 106.8m |
Accounts Payable | 40.6m |
Accrued Liabilities | 7.7m |
Short-Term Debt | 26.4m |
Other Current Liabilities | 32m |
Non-Current Liabilities | 120.6m |
Long-Term Debt | 118.3m |
Other Non-Current Liabilities | 2.3m |
Earnings Waterfall
Paragon Care Ltd
Revenue
|
467.5m
AUD
|
Cost of Revenue
|
-275.5m
AUD
|
Gross Profit
|
192m
AUD
|
Operating Expenses
|
-154.4m
AUD
|
Operating Income
|
37.6m
AUD
|
Other Expenses
|
-23.9m
AUD
|
Net Income
|
13.7m
AUD
|
Free Cash Flow Analysis
Paragon Care Ltd
PGC Profitability Score
Profitability Due Diligence
Paragon Care Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Paragon Care Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
PGC Solvency Score
Solvency Due Diligence
Paragon Care Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Paragon Care Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PGC Price Targets Summary
Paragon Care Ltd
According to Wall Street analysts, the average 1-year price target for PGC is 0.32 AUD with a low forecast of 0.31 AUD and a high forecast of 0.33 AUD.
Shareholder Return
PGC Price
Paragon Care Ltd
Average Annual Return | 1.43% |
Standard Deviation of Annual Returns | 51.91% |
Max Drawdown | -81% |
Market Capitalization | 227.1m AUD |
Shares Outstanding | 681 682 300 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. The company is headquartered in Melbourne, Victoria. The firm provides medical equipment, medical devices and consumables for the Australian and New Zealand healthcare markets. Its product portfolio includes critical care, diagnostics, neonatal, medical products and consumables, orthopaedics, surgical, technology and connectivity, urology, veterinary and services. Its brands consist of Designs For Vision, Electro Medical Group, Immulab, Immuno, Insight Surgical, LabGear Australia, Lovell Surgical Solutions, Meditron, Medtech Solutions, Medtek, Paragon Care, Scanmedics, Surgical Specialties, Total Communications, Western Biomedical, Rem Systems Medical and Rem Systems Veterinary. The firm also offer equipment repair, maintenance and total equipment management through Paragon Care Service & Technology.
Contact
IPO
Employees
Officers
The intrinsic value of one PGC stock under the Base Case scenario is 0.45 AUD.
Compared to the current market price of 0.34 AUD, Paragon Care Ltd is Undervalued by 25%.